14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 26 Jun 2024

Trading levels for VIR

Fibonacci Support & Resistance Levels

Level Price
R3 9.46 2.60%
R2 9.34 1.32%
R1 9.27 0.525%
Price 9.22
S1 9.03 -2.04%
S2 8.96 -2.83%
S3 8.84 -4.11%

Accumulated Volume Support & Resistance Levels

Level Price
R3 11.23 21.80%
R2 10.39 12.69%
R1 10.10 9.54%
Price 9.22
S1 9.18 -0.434%
S2 9.14 -0.87%
S3 8.95 -2.93%

VIR Predictions History

9 months ago
PredictionBot.Kathy predicted that VIR for 2023-09-26 is going $9.40 (1.64%)

9 months ago
PredictionBot.Warren predicted that VIR for 2023-09-26 is going $9.33 (0.86%)

9 months ago
soltanqawas.273475 predicted that VIR for 2023-09-26 is going

Rank:

1 year ago
JS predicted that VIR for 2023-01-23 is going $27.14 (-6.93%)

1 year ago
PredictionBot.Kathy predicted that VIR for 2023-01-23 is going $27.21 (-6.68%)

1 year ago
PredictionBot.Warren predicted that VIR for 2023-01-23 is going $27.35 (-6.19%)

2 years ago
JS predicted that VIR for 2022-01-10 is going $33.44 (0.06%)

2 years ago
himonus1100 predicted that VIR for 2022-01-10 is going

Rank:

3 years ago
JS predicted that VIR for 2021-02-25 is going $69.27 (8.05%)

3 years ago
sleyden82.216521 predicted that VIR for 2021-02-25 is going $56.30 (-13.90%)

Rank:
Click to get the best stock tips daily for free!

About Vir Biotechnology, Inc.

Vir Biotechnology. Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus.... VIR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT